Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:08:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:42:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Removed the 403 error page elements (doctype, meta tags and Home link), resulting in the study details page becoming accessible again.
    Difference
    0.5%
    Check dated 2026-09-28T16:30:40.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The Study Record page is now rendering a 403 Forbidden error instead of the usual study details, signaling an access issue. The UI reflects an error state rather than updated or added study content.
    Difference
    18%
    Check dated 2026-09-21T20:20:34.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a minor update to the page's version metadata rather than substantive changes to study details.
    Difference
    0.1%
    Check dated 2026-08-31T17:00:23.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The study page now displays an error/unavailable message, replacing the usual study details and navigation.
    Difference
    17%
    Check dated 2026-08-10T10:40:41.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.